Isoxazole derivative (±)- 4 and the three pairs of stereoisomeric 3-bromo-isoxazolyl amino alcohols ( S, R)-(−)- 7a/( R, R)-(+)- 7b, ( S, R)-(−)- 8a/( R, R)-(+)- 8b, and ( S, R)-(−)- 9a/( R, R)-(+)- 9b were synthesized and assayed for their affinity and efficacy at human β 1-, β 2-, and β 3-adrenergic receptors (β-ARs) in membranes from Chinese hamster ovary (CHO) cells stably transfected with the respective receptor subtype. Whereas derivative (±)- 4 did not bind at all three β-ARs, stereoisomers ( S, R)- 7a-( S, R)- 9a behaved as high-affinity ligands at β 1- and, particularly, at β 2-ARs ( K i 2.82–66.7 nM). The K i values of isomers ( R, R)- 7b-( R, R)- 9b at β 1- and β 2-subtypes were about 30–100 times higher than those of their ( S, R)- 7a– 9a counterparts, indicating a sizable stereochemical effect. The affinity at β 3-ARs was negligible for all the investigated compounds. When submitted to a functional assay, the three stereoisomeric pairs showed a comparable pattern of efficacy at all three β-AR subtypes. The highest value of efficacy (75–90%) was observed at β 2-ARs, whereas all compounds behaved as partial agonists (30–60%) at the β 3-subtype. The lowest degree of efficacy (15–35%) was found at β 1-ARs. The affinity/efficacy profile of the derivatives under study has been compared with that of the two model compounds, Broxaterol [(±)- 1] and BRL 37344 [(±)- 6].